Drug risks raise doubt about ads
527417
Some want tighter control of ads, in part to stem overuse of pills.
2669
Users of an anti-arthritis drug linked by a study to an increased risk of heart attacks and strokes are urged not to panic.
411970
Unwary customers could suffer from supplements' lack of government scrutiny.
159402
AstraZeneca&#39;s recent full-page newspaper advertisements defending the safety of its cholesterol-lowering pill, Crestor, are &quot;false and misleading,&quot; in part because
631592
A report last week tying the Type 2 diabetes pill Avandia to increased risk for heart attack and heart-related deaths prompted a flood of calls to local doctors and Internet postings from patients seeking advice about whether to continue taking the commonly prescribed medication.
185146
Two revelations last week of Food and Drug Administration foot-dragging place in doubt whether the agency can effectively serve and protect consumers.
305432
Our position is: Greater drug safety needs to be coupled with awareness that some risk is inherent in medicine. When it comes to assurances of drug safety, consumers would be advised to heed George Bernard Shaw&#39;s warning to beware of what they wish for.
262080
There are two problems at the FDA. The first is that the Fraud and Drug Administration clearly puts the protection of Big Pharma profits as its primary mission, rather than protecting the public from dangerous drugs.
518059
Scientists and European regulators are now questioning the safety of other pain relievers like Vioxx, saying they also might raise the risk of heart attack and stroke.
249661
About two-thirds of Food and Drug Administration scientists are less than fully confident in the agency's monitoring of the safety of prescription drugs now being sold.
493704
Pfizer is pulling its radio, TV, newspaper and magazine advertising for Celebrex in the wake of a study that links high doses of the popular arthritis to an increased risk of heart attack, but the company plans to keep Celebrex on the market.
386658
The U.S. Food and Drug Administration is facing new questions about its ability to police the safety of medicines after they reach the market following concerns about a widely used diabetes drug.
697522
If its latest drug isn't approved, the pharmaceutical could face trouble.
73726
(WebMD) New research is raising concerns about the safety of a preservative that is commonly found in shampoos and other commercially available cosmetics.
138187
Its new ad campaign may not be focused on the right people.
372192
A clinical trial of Zetia, a widely used cholesterol drug, has raised questions about its effectiveness and the behavior of pharmaceutical companies that conducted the study.
146686
Drug companies rushing to fill the vacuum left by Merck &amp; Co.'s withdrawal of its best-selling arthritis drug Vioxx are flooding the airwaves with competing advertising claims that are bewildering many patients.